Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Efficacy, Team × Immune Checkpoint Inhibitors × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sarcopenia 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Efficacy, Team 1 Colorectal Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 1 Nivolumab 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06693440 2024-11-18

The Immune Assessment of PD-1 Antibody Therapy in Tumor

Henan Cancer Hospital

Efficacy, Team

Data powered by HemOnc (CC BY 4.0) Colophon ⚡